0001209191-11-059456.txt : 20111205
0001209191-11-059456.hdr.sgml : 20111205
20111205155601
ACCESSION NUMBER: 0001209191-11-059456
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111201
FILED AS OF DATE: 20111205
DATE AS OF CHANGE: 20111205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC
CENTRAL INDEX KEY: 0001008848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 SKYLINE DRIVE
CITY: HAWTHORNE
STATE: NY
ZIP: 10532
BUSINESS PHONE: 914-347-4300
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAWRENCE DAVID
CENTRAL INDEX KEY: 0001272353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50513
FILM NUMBER: 111243086
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 15 SKYLINE DRIVE
CITY: HAWTHORNE
STATE: NY
ZIP: 10532
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2011-12-01
0
0001008848
ACORDA THERAPEUTICS INC
ACOR
0001272353
LAWRENCE DAVID
15 SKYLINE DRIVE
HAWTHORNE
NY
10532
0
1
0
0
Chief Financial Officer
Common Stock
2011-12-01
4
S
0
9896
22.92
D
16249
D
Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.73 to $23.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ David Lawrence
2011-12-05